The In Vitro Diagnostic Medical Devices Regulations 2000 © Crown Copyright 2000 Statutory Instruments printed from this website are printed under the superintendence and authority of the Controller of HMSO being the Queen's Printer of Acts of Parliament. The legislation contained on this web site is subject to Crown Copyright protection. It may be reproduced free of charge provided that it is reproduced accurately and that the source and copyright status of the material is made evident to users. It should be noted that the right to reproduce the text of Statutory Instruments does not extend to the Queen's Printer imprints which should be removed from any copies of the Statutory Instrument which are issued or made available to the public. This includes reproduction of the Statutory Instrument on the Internet and on intranet sites. The Royal Arms may be reproduced only where they are an integral part of the original document. The text of this Internet version of the Statutory Instrument which is published by the Queen's Printer of Acts of Parliament has been prepared to reflect the text as it was Made. A print version is also available and is published by The Stationery Office Limited as the The , ISBN 0 11 099260 1. The print version may be purchased by clicking here. Braille copies of this Statutory Instrument can also be purchased at the same price as the print edition by contacting TSO Customer Services on 0870 600 5522 or e-mail:customer.services@tso.co.uk. Further information about the publication of legislation on this website can be found by referring to the Frequently Asked Questions. To ensure fast access over slow connections, large documents have been segmented into "chunks". Where you see a "continue" button at the bottom of the page of text, this indicates that there is another chunk of text available.
The Secretary of State, being a Minister designated for the purposes of section 2(2) of the European Communities Act 1972[1] in relation to measures relating to medical devices[2], in exercise of the powers conferred by the said section 2(2), in exercise, with the consent of the Treasury, of the powers conferred by section 56(1) and (2) of the Finance Act 1973[3], in exercise of the powers conferred by sections 11 and 27(2) of the Consumer Protection Act 1987[4], and in exercise of all other powers enabling him in that behalf, after consultation in accordance with section 11(5) of the Consumer Protection Act 1987 with organisations appearing to him to be representative of interests substantially affected by these Regulations, with such other persons considered by him appropriate and with the Health and Safety Commission, hereby makes the following Regulations: - Citation and commencement 1. These Regulations may be cited as the In Vitro Diagnostic Medical Devices Regulations 2000 and shall come into force on 7th June 2000. Interpretation 2. - (1) In these Regulations, unless the context otherwise requires -
(b) an invasive sampling medical device; or (c) a medical device which is directly applied to the human body for the purpose of obtaining a specimen;
(b) is intended by the manufacturer to be used in vitro for the examination of specimens, including blood and tissue donations, derived from the human body, solely or principally for the purpose of providing information -
(ii) concerning a congenital abnormality, (iii) to determine the safety and compatibility of donations, including blood and tissue donations, with potential recipients, or (iv) to monitor therapeutic measures,
and includes a specimen receptacle but not a product for general laboratory use, unless that product, in view of its characteristics, is specifically intended by its manufacturer to be used for in vitro diagnostic examination;
(b) any other person who assembles, packages, processes, fully refurbishes or labels one or more ready-made products or assigns to them their intended purpose as a device with a view to their being placed on the market under his own name, apart from a person who assembles or adapts devices already on the market to their intended purpose for an individual patient;
(2) In these Regulations, unless the context otherwise requires, a reference -
(b) in a regulation to a numbered or lettered paragraph is to the paragraph of that regulation bearing that number or letter; (c) in a paragraph to a numbered or lettered sub-paragraph is to the sub-paragraph in that paragraph bearing that number or letter; and (d) to a numbered article or Annex is to the article or Annex of the Directive bearing that number.
Scope of the Regulations
(b) in circumstances where that device has been placed on the market or put into service,
unless that device meets those essential requirements set out in Annex I which apply to it.
(b) the relevant device is a device for self-testing, in which case the instructions for use and the label must include a translation into the official language of the member State in which the device reaches its final user.
(5) A relevant device shall be presumed to comply with an essential requirement if it conforms as respects that requirement to a relevant national standard.
(b) is in a visible, legible and indelible form; and (c) is accompanied by the relevant notified body identification number, if there is a relevant notified body identification number for that device.
(2) Subject to regulation 8, no person shall place on the market, put into service or supply (if that supply is also a placing on the market or putting into service) a relevant device unless a CE marking, meeting the requirements set out in Annex X, appears on -
(b) the instructions for use for that device,
and that CE marking is accompanied by the relevant notified body identification number, if there is a relevant notified body identification number for that device.
(b) the instructions for use for a relevant device; or (c) any sales packaging for a relevant device,
which is likely to mislead a third party with regard to the meaning or the graphics of the CE marking or which reduces the visibility or legibility of the CE marking.
(b) the marking of the device indicates that the device only satisfies the set of arrangements chosen by the manufacturer; and (c) whichever set of arrangements is chosen, the particulars of the other directive, as published in the Official Journal of the European Communities, are given in the documents, notices or instructions accompanying the device.
Relevant devices not ready for use
(b) supply a relevant device -
(ii) in circumstances where that device has been placed on the market or put into service,
which is not ready for use.
Exemptions from regulations 4, 5 and 7
(b) a visible sign clearly indicates that the device cannot be marketed or put into service until it complies with the requirements of the Directive or these Regulations.
(2) Regulations 4, 5 and 7 shall not apply where, following a duly justified request and in the interests of the protection of health, the Secretary of State has authorised the placing on the market or putting into service of a particular relevant device or relevant devices of a particular class or description without a CE marking.
(b) declares, having taken into account where appropriate the matters referred to in article 9(5), that the device meets the provisions of the Directive which apply to it; and (c) ensures that the device meets the provisions of the Directive which apply to it.
(2) A relevant device which is a device for self-testing but which is not referred to in a list in Annex II may bear a CE marking only if its manufacturer or his authorised representative -
(ii) Annex IV, or (iii) Annex V and either Annex VI or Annex VII;
(b) declares, having taken into account where appropriate the matters referred to in article 9(5), that the device meets the provisions of the Directive which apply to it; and
(3) A relevant device referred to in List A in Annex II may bear a CE marking only if its manufacturer or his authorised representative -
(ii) Annexes V and VII;
(b) declares, having taken into account where appropriate the matters referred to in article 9(5), that the device meets the provisions of the Directive which apply to it; and
(4) A relevant device referred to in List B in Annex II may bear a CE marking only if its manufacturer or his authorised representative -
(ii) Annexes V and VI, or (iii) Annexes V and VII;
(b) declares, having taken into account where appropriate the matters referred to in article 9(5), that the device meets the provisions of the Directive which apply to it; and
Supplemental provisions relating to conformity assessment procedures
(b) the technical documentation referred to in Annexes III to VIII relating to that device; and (c) the decisions, reports and certificates of notified bodies relating to that device,
for a period ending five years after the manufacture of the last product.
(b) place on the market or supply (if that supply is also a placing on the market) a product which has affixed to it a CE marking for a relevant device if that product is not a relevant device.
(2) No person shall provide information comprising a CE marking for a relevant device on a product, the instructions for use for a product or the sales packaging of a product if the product is not a relevant device.
(b) ensures that -
(ii) the relevant requirements of the Directive are complied with as respects that device; and
(c) undertakes to keep available, and keeps available, for the Secretary of State, for a minimum period of five years after the end of the performance evaluation documentation allowing an understanding of the design, manufacture and performances of the device, including the expected performances, so as to allow assessment of conformity of the device with the requirements of these Regulations.
Designation of authorised representatives for registration purposes
(b) makes available a device for performance evaluation,
shall designate an authorised representative as the person responsible for performing the functions of an authorised representative referred to in regulation 14.
(b) in the case of an authorised representative, sufficient evidence that he is the authorised representative of the manufacturer; (c) in relation to a new relevant device, evidence that the device is a new relevant device, and for the purposes of this regulation a device is a " new relevant device" if -
(ii) use of the device involves analytical technology not continuously used in connection with a given analyte or other parameter on the Community market during the previous three years;
(d) in relation to a new relevant device, if requested by the Secretary of State (such a request only being permissible within two years from the date on which the Secretary of State was notified that the device was a new relevant device, and on justified grounds), a report relating to the experience gained with the device subsequent to its being placed on the market;
(ii) if requested by the Secretary of State, the labelling and the instructions for use for when the device is placed on the market or put into service within the United Kingdom;
(h) in relation to devices for performance evaluation which relate either to devices referred to in a list in Annex II or to devices for self-testing, all data allowing for identification of such devices, the analytical and, where appropriate, diagnostic parameters as referred to in Section 3 of Part A of Annex I,
and shall notify him of any significant change to that information including discontinuation of the placing on the market of the device.
(b) he considers that it is no longer a body in respect of which the criteria set out in Annex IX are met,
and the Secretary of State may also withdraw any designation of a body under paragraph (1) if it fails to pay any fee payable under the 1995 Regulations.
(b) withdrawing designation under paragraph (5),
otherwise than at the notified body's request, the Secretary of State shall give to the notified body an opportunity to make representations to him in writing and shall take into account any such representations as are made.
(b) any premises occupied, or plant or equipment used, by a manufacturer where the body is a notified body undertaking any task in relation to that manufacturer,
and may take into account for the purposes of his decision the results of any such inspection and any refusal to afford him such facilities or assistance as he may reasonably require in order to carry out any such inspection.
(b) on request, all certificates issued or refused,
and shall also make available to them, on request, any or all additional relevant information.
(b) a certificate issued by it should not have been issued,
it may (having regard in particular to the principle of proportionality and the ability of the manufacturer to take appropriate corrective measures) suspend or withdraw the certificate issued in respect of that device or place restrictions on it, and in such cases, or in cases where the notified body is aware of circumstances in which the Secretary of State may need to take action pursuant to regulation 18 or 19, the notified body shall inform the Secretary of State thereof.
(b) the commercial rate normally charged in respect of profit for that work or similar work.
(4) The UK notified body may require payment of a fee, or a reasonable estimate of the fee, in advance of carrying out the work in respect of which the fee is payable and as a condition of doing that work.
(b) any application made by it under section 16 of the 1987 Act for an order for forfeiture of any such device; and (c) any other thing done by it in respect of such a device for the purposes of, or in connection with the operation of, sections 14 to 17 of the 1987 Act.
(6) The powers conferred by section 13 of the 1987 Act to serve prohibition notices and notices to warn are exercisable in relation to non-conforming devices as they are exercisable in relation to relevant goods which the Secretary of State considers are unsafe (as well as being exercisable in relation to such goods), and in relation to non-conforming devices, Schedule 2 to the 1987 Act shall have effect as if references to goods being unsafe or safe were references to relevant devices being or not being non-conforming devices.
(ii) to which a CE marking has or should have been applied following a conformity assessment procedure set out in the Directive, and -
(bb) they do not conform to the design or type described in any relevant EC design-examination certificate or EC type-examination certificate; or
(b) devices for performance evaluation which, whether or not the Secretary of State considers them unsafe, are devices in respect of which there is a failure to comply with these Regulations.
(7) The Secretary of State shall perform, as respects the United Kingdom, the functions of a member State under article 11(1) to (3).
(b) stating that the enforcement authority suspects the device is a device in respect of which there is failure to comply with these Regulations and the reasons for that suspicion; (c) specifying the relevant provision of these Regulations; (d) requiring the person on whom the notice is served -
(ii) to provide evidence within that period to the satisfaction of the enforcement authority that all the provisions of these Regulations have been complied with so far as they relate to that device; and
(e) warning the person on whom the notice is served that unless the requirements of sub-paragraph (d) are met, further action may be taken under these Regulations or the 1987 Act in respect of that device or any device of the same type supplied by that person.
(2) Where an enforcement authority serves a notice referred to in paragraph (1), section 14, 16 or 17 of the 1987 Act shall not be applied as respects any device to which the notice relates until the period referred to in paragraph (1)(d) has expired and unless, in relation to the alleged failure to comply with these Regulations, at the expiry of that period the person on whom the notice was served has failed to comply with its requirements.
(b) in vitro diagnostic medical devices, accessories to such devices or devices for performance evaluation of a particular class or description,
in order to protect the health or safety of any individual or of individuals of any class or description, they may serve on any person a notice ("a restriction notice") including such directions restricting the availability of that device or those devices as appear to them to be necessary in order to protect the health or safety of that individual or individuals of that class or description.
(b) under section 16 or 17 of the 1987 Act (which relate to forfeiture of goods), the court or the sheriff may make an order setting aside the restriction notice,
if the court or the sheriff is satisfied that the restriction notice should not have been served or should be withdrawn.
(b) under paragraph 7(b) is an order or decision not to make an order under section 16 of the 1987 Act,
and a decision, in Scotland, not to make an order under paragraph 7(b) may, within 21 days of the decision, be appealed to the High Court by Bill of Suspension on the ground of an alleged miscarriage of justice, and the appeal shall be treated in the same way as an appeal under section 17(8) of the 1987 Act.
(b) a device for performance evaluation and the manufacturer or his authorised representative does not indicate, directly or indirectly, that it is a device which is subject to the provisions of these Regulations,
if the device satisfies the requirements of the laws of that part of the United Kingdom in which it is placed on the market as in force on 7th December 1998.
(b) a device for performance evaluation and the manufacturer or his authorised representative does not indicate, directly or indirectly, that it is a device which is subject to the provisions of these Regulations,
if the device satisfies the requirements of the laws of that part of the United Kingdom in which it is put into service as in force on 7th December 1998.
(b) of the legal remedies available to that person and of any time limits which apply to their exercise; and (c) if he was not entitled under the 1987 Act to make representations in respect of the decision, that the decision maker will, on request, review the decision and in the course of so doing will give him or his authorised representative an opportunity to make representations in respect of the decision.
(2) Except in cases where urgent action is justified (in particular by public health requirements), if a UK notified body, the Secretary of State or any other enforcement authority is considering making a decision referred to in paragraph (1), they or he shall give the manufacturer or his authorised representative an opportunity to make representations to them or him before the decision is taken. 1. In regulation 2(1) of the 1994 Regulations (interpretation) -
2.
In regulation 3(2) of the 1994 Regulations (application of the Regulations), for sub-paragraph (a) there shall be substituted the following sub-paragraph -
3.
After regulation 12 of the 1994 Regulations (general provisions relating to conformity assessment procedures) there shall be inserted the following regulation -
12A. - (1) No person shall -
(b) place on the market a product which has affixed to it the CE marking for a device if that product is not a device.
(2) No person shall provide information comprising a CE marking for a relevant device on -
(b) the instructions for use for a product; or (c) the sales packaging for a product,
if the product is not a device.
(ii) that product is not a device;
(b) expose or possess for supply a product which has affixed to it a CE marking for a device if -
(ii) that product is not a device.".
4.
In regulation 14 of the 1994 Regulations (registration of persons placing devices on the market) -
(c) supply the Secretary of State, if the device is a Class IIb or III device and if the Secretary of State so requests, with all data allowing for the identification of the device together with the label and the instructions for use for when the device is put into service within the United Kingdom."; and
(b) after sub-paragraph (b) of paragraph (3) there shall be added the following -
(c) in the case of an authorised representative of the manufacturer, the fact that he is the manufacturer's authorised representative, and he shall furnish the Secretary of State with sufficient evidence that he is an authorised representative of the manufacturer.".
5.
In regulation 16 of the 1994 Regulations (clinical investigations) -
(b) after paragraph (1), there shall be inserted the following paragraph -
(b) if the ethics committee opinion required under Section 2.2 of Annex VIII is not available, at any time after a favourable opinion in respect of the investigational plan for the intended investigation is delivered by the committee,
but that written notice may at any time be withdrawn by the Secretary of State.
6.
In regulation 17 of the 1994 Regulations (notified bodies), after paragraph (7) there shall be inserted the following paragraphs -
(b) on request, all certificates issued or refused,
and they shall also make available to them, on request, any or all additional relevant information.
(b) a certificate should not have been issued,
it may (having regard in particular to the principle of proportionality and the ability of the manufacturer to take appropriate corrective measures) suspend or withdraw the certificate issued in respect of that device or place restrictions on it, and in such cases, or in cases where the notified body is aware of circumstances in which the Secretary of State may need to take action pursuant to regulation 19 or 19A, the notified body shall inform the Secretary of State thereof.
7.
For paragraph (1) of regulation 18 of the 1994 Regulations (prohibition on supply etc.) there shall be substituted the following paragraph -
(b) in circumstances where that device has been placed on the market or put into service,
if the device does not comply with the relevant essential requirements, is prohibited.".
8.
- (1) In paragraph (3) of regulation 19 of the 1994 Regulations (enforcement etc.), after the words "and accordingly" there shall be added the words " but subject to paragraph (3A),".
(3) For paragraphs (6) and (7) of regulation 19 of the 1994 Regulations there shall be substituted the following paragraphs -
(b) to which a CE marking has or should have been applied following the EC declaration of conformity assessment procedure set out in the Directive, and -
(ii) they do not conform to the design or type described in any relevant EC design-examination or EC type-examination certificate.
(7) Except in the case of a device which in the opinion of an enforcement authority is likely to compromise the health or safety of any person, where an enforcement authority has reasonable grounds for suspecting that a device is a device in respect of which there is a failure to comply with these Regulations, that authority may serve upon the manufacturer or his authorised representative a notice -
(b) stating that the enforcement authority suspects the device is a device in respect of which there is failure to comply with these Regulations and the reasons for that suspicion; (c) specifying the relevant provision of these Regulations; (d) requiring the person on whom the notice is served -
(ii) to provide evidence within that period to the satisfaction of the enforcement authority that all the provisions of these Regulations have been complied with so far as they relate to that device; and
(e) warning the person on whom the notice is served that unless the requirements of sub-paragraph (d) are met, further action may be taken under these Regulations or the 1987 Act in respect of that device or any device of the same type supplied by that person.".
9.
After regulation 19 of the 1994 Regulations there shall be inserted the following regulation -
19A. - (1) Where an enforcement authority is of the opinion that it is necessary to restrict the availability of a particular device, or of devices of a particular class or description, in order to protect the health or safety of any individual or of individuals of any class or description, they may serve on any person a notice ("a restriction notice") including such directions restricting the availability of that device or those devices as appear to them to be necessary in order to protect the health or safety of that individual or individuals of that class or description. (2) The enforcement authority responsible for serving a restriction notice may, in appropriate circumstances, withdraw the notice. (3) A direction in a restriction notice that has not been withdrawn by an enforcement authority or set aside by an order of a court or a sheriff is a safety provision for the purposes of sections 14 to 17 of the 1987 Act. (4) Where, in the course of or as a result of enforcement action in relation to a suspected contravention of a direction in a restriction notice, an application has been made to a magistrates' court or a sheriff -
(b) under section 16 or 17 of the 1987 Act (which relate to forfeiture of goods), the court or the sheriff may make an order setting aside the restriction notice,
if the court or the sheriff is satisfied that the restriction notice should not have been served or should be withdrawn.
(b) under paragraph 4(b) is an order or decision not to make an order under section 16 of the 1987 Act,
and a decision, in Scotland, not to make an order under paragraph 4(b) may, within 21 days of the decision, be appealed to the High Court by Bill of Suspension on the ground of an alleged miscarriage of justice, and the appeal shall be treated in the same way as an appeal under section 17(8) of the 1987 Act.".
10.
In paragraph (1) of regulation 22 of the 1994 Regulations (transitional provisions), after sub-paragraph (b) there shall be added the following -
(c) shall prohibit the putting into service before 30th June 2001 of a device which -
(ii) satisfies the requirements of the laws of that part of the United Kingdom in which it is put into service as in force on 31st December 1994.".
11.
In paragraph (1) of regulation 23 of the 1994 Regulations (notification of decisions etc.) -
(b) after sub-paragraph (b) there shall be inserted the following -
(c) a statement, if the applicant was not entitled under the 1987 Act to make representations in respect of the decision, that the decision maker will, on request, review the decision and in the course of so doing will give him or his authorised representative an opportunity to make representations in respect of the decision.".
1. In regulation 2 of the 1995 Regulations (interpretation) -
2.
After regulation 6 of the 1995 Regulations (withdrawals) there shall be inserted the following regulations -
7. Any person required to supply the Secretary of State with any information under regulation 14 of the 1994 Regulations shall, in respect of the processing of that information with regard to the possible registration of devices by the Secretary of State or possible changes to registration details, pay to the Secretary of State a fee of £70, and that fee -
(b) shall accompany that information when it is supplied.
(2) Any person required to supply the Secretary of State with any information under regulation 14 of the 2000 Regulations shall, in respect of the processing of that information with regard to the possible registration of in vitro diagnostic medical devices by the Secretary of State or possible changes to registration details, pay to the Secretary of State a fee of £70, and that fee -
(b) shall accompany that information when it is supplied.
Fees payable in connection with the designation of UK notified bodies under regulation 15 of the 2000 Regulations
(b) in all other cases, a fee of £2,600.
(2) A corporate or other body that applies to the Secretary of State for a variation under regulation 15(4) of the 2000 Regulations of the tasks that the body may carry out shall, in connection with that application for a variation, pay to the Secretary of State a fee of £1,300.
(ii) the actual costs of travel, accommodation and subsistence, and (iii) out of pocket expenses;
(b) in respect of any other inspection pursuant to regulation 15(7)(a) of those Regulations, a fee of £2,600, plus -
(ii) the actual costs of travel, accommodation and subsistence, and (iii) out of pocket expenses; and
(c) in respect of an inspection pursuant to regulation 15(7)(b) of those Regulations, a fee of £2,600, plus -
(ii) the actual costs of travel, accommodation and subsistence, and (iii) out of pocket expenses.
(4) A fee under this regulation -
(ii) shall accompany the application when it is made; (b) in connection with an inspection, shall be payable within one month of receipt by the body of a written notice from the Secretary of State requiring payment of the fee.
Unpaid fees
(b) refund the whole or part of any fee paid pursuant to these Regulations.".
3.
In the Table set out in the Schedule to the 1995 Regulations[14], in the entries in Column 3 -
(b) after the words "any one date," at each place where they occur, there shall be added the words "and at a rate of £51.39 per hour for time spent travelling,".
(This note is not part of the Regulations) These Regulations implement Directive 98/79/EC of the European Parliament and of the Council on in vitro diagnostic medical devices (" the Directive"). Regulation 2 is an interpretation provision. Regulation 3 sets out the scope of the Regulations, and indicates which in vitro diagnostic medical devices are covered by the Regulations ("relevant devices"). Regulation 4 provides that relevant devices placed on the market, put in to service or (in certain circumstances) supplied must comply with the relevant essential requirements, as defined by reference to the essential requirements specified in Annex I of the Directive. Regulation 4 also sets out the factors to be taken into consideration when deciding whether a relevant device meets the essential requirements. Regulation 5 requires relevant devices, their instructions for use and their sales packaging to bear a CE marking which meets the requirements of the Directive. Regulation 6 deals with the CE marking of relevant devices that come within the scope of more than one Directive, and regulation 7 contains prohibitions relating to relevant devices which are not ready for use. Regulation 8 specifies exemptions from the requirements of regulations 4, 5 and 7, including exemptions in the interests of the protection of health. Regulation 9 sets out the procedures which manufacturers must follow for affixing the CE marking to relevant devices, and regulation 10 contains supplemental provisions relating to those procedures, including a number of additional requirements on manufacturers or their authorised representatives. Regulation 11 creates prohibitions relating to the affixing of a CE marking for a relevant device to a product which is not a relevant device. Regulation 12 specifies, by reference to Annex VIII of the Directive, the rules in respect of making available devices for performance evaluation. Regulations 13 and 14 relate to the registration of manufacturers, or their authorised representatives, of relevant devices and devices for performance evaluation, and the information they need to supply to the Secretary of State for registration purposes. Regulation 15 deals with the designation of United Kingdom notified bodies and the circumstances in which such designations may be varied and withdrawn. Regulation 16 specifies the functions of such bodies. Regulation 17 makes provision for the fees chargeable by the notified bodies for work done in connection with the conformity assessment procedures set out in the Annexes to the Directive. Regulation 18 specifies the responsibilities for enforcement in relation to the Regulations, and it provides that the Regulations are to be regarded for the purposes of enforcement as safety regulations as defined in the Consumer Protection Act 1987, although they are made partly in exercise of other powers. It also designates the Secretary of State as responsible for certain public health monitoring activities. Regulation 19 contains a notice procedure for requiring compliance where there is a failure to comply with the requirements of the Regulations, and a further notice procedure for applying restrictions to the availability of devices where this is necessary to ensure the protection of health or safety. Regulation 20 contains transitional provisions, and regulation 21 contains procedural requirements in relation to the notification of decisions by the Secretary of State, other enforcement authorities and the United Kingdom notified bodies. Regulation 22 gives effect to Schedule 1 which contains amendments to the Medical Devices Regulations 1994 which are consequential upon amendments to Council Directive 93/42/EEC concerning medical devices[15] that were included in the Directive. The changes to Council Directive 93/42/EEC were essentially to align the requirements of the two Directives. Some additional changes have also been made to the 1994 Regulations to align the implementation approach adopted in those Regulations with the approach adopted in these Regulations, and there are also changes to the system set out in the 1994 Regulations for obtaining the approval of ethics committees and the Secretary of State for proposed clinical investigations. Regulation 23 gives effect to Schedule 2 which contains amendments to the Medical Devices Fees Regulations 1995 arising out of both the new scheme for in vitro diagnostic medical devices and the scheme in the Medical Devices Regulations 1994. There are new fees in connection with the registration scheme for relevant devices and devices for performance evaluation, as well as a new fee in connection with the registration scheme for certain medical devices. Notified bodies are also required to pay fees in relation to their designation scheme, and for certain inspections by the Secretary of State. The amendments also include some new enforcement provisions for the 1995 Regulations. A Regulatory Impact Assessment in relation to these Regulations has been placed in the libraries of both Houses of Parliament, and copies can be obtained from the Medical Devices Agency, Hannibal House, Elephant and Castle, London SE1 6TQ. Notes: [1] 1972 c. 68.back [2] The Secretary of State was designated in relation to measures relating to active implantable medical devices in S.I. 1991/2289, and in relation to measures relating to medical devices other than active implantable medical devices in S.I. 1993/2661.back [6] S.I. 1995/2487; amended by S.I. 1997/694.back [7] O.J. No. L331, 7.12.1998, p. 1.back [8] O.J. L204, 21.7.1998, p. 37; amended by Directive 98/48/EC (O.J. 217, 5.8.1998, p. 18).back [9] Council of Europe (ETS No. 164), Orviedo, 4.4.1997.back [10] As amended by regulation 23 of, and Schedule 2 to, these Regulations.back [11] See sections 11(1) and 45(1) of that Act.back [12] See section 45(1) of that Act.back [13] See section 11(7) of that Act.back [14] Amended by regulation 2 of S.I. 1997/694.back [15] O.J. No. L169, 12.7.1993, p. 1.back
ISBN 0 11 099260 1
|
|
| ||
| We welcome your comments on this site | © Crown copyright 2000 | Prepared 23 May 2000 |